Subcutaneous Infliximab in Refractory Crohn’s Disease Patients: A Possible Biobetter?

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10640858 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature